Streetbeat News

Price Targets

IBM

B of A Securities analyst Wamsi Mohan maintains a Buy rating on IBM and raises the price target from $152 to $160.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 4:13 pm

LYFT

Tigress Financial analyst Ivan Feinseth has maintained a 'Buy' rating on Lyft (NASDAQ:LYFT) but lowered the price target from $60 to $22.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 4:11 pm

PNT

Jefferies analyst Chris Howerton has assumed POINT Biopharma Global (NASDAQ:PNT) with a Buy rating and raised the price target to $14.

Portfolio Pulse from richadhand@benzinga.com

July 20, 2023 | 4:11 pm

BZ

Citigroup analyst Brian Gong has initiated coverage on Kanzhun (NASDAQ:BZ) with a Buy rating and a price target of $19.

Portfolio Pulse from richadhand@benzinga.com

July 20, 2023 | 4:10 pm

GFL

TD Securities analyst Tim James has maintained a 'Buy' rating on GFL Environmental (NYSE:GFL) and raised the price target from C$58 to C$59.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 4:09 pm

VIR

HC Wainwright & Co. analyst Patrick Trucchio has reiterated a 'Buy' rating on Vir Biotechnology (NASDAQ:VIR) and maintained a $100 price target.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 4:07 pm

APLS

Citigroup analyst Yigal Nochomovitz has maintained a 'Buy' rating on Apellis Pharmaceuticals but lowered the price target from $106 to $80.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 4:06 pm

NFLX

Oppenheimer analyst Jason Helfstein maintains an Outperform rating on Netflix (NASDAQ:NFLX) and raises the price target from $500 to $515.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 4:03 pm

UNH

A significant bearish stance has been taken on UnitedHealth Group (NYSE:UNH) by a large investor, as indicated by unusual options activity. The sentiment among these big-money traders is split, with 40% bullish and 60% bearish. Over the last 3 months, the targeted price range for UnitedHealth Group has been between $230.0 and $550.0. The company's stock price is currently up 0.72% at $507.35. Several financial institutions have maintained their ratings on UnitedHealth Group, with price targets ranging from $520 to $580.

Portfolio Pulse from Benzinga Insights

July 20, 2023 | 4:01 pm

RPT

Mizuho analyst Haendel St. Juste maintains a Neutral rating on RPT Realty (NYSE:RPT) and raises the price target from $9.5 to $11.

Portfolio Pulse from richadhand@benzinga.com

July 20, 2023 | 4:00 pm